What is the current price and trading status of IGPH.SW stock?

IGPH.SW stock is trading at **CHF0.0015** pre-market on 05 Mar 2026, down **-25.00%** with volume **2,033,000**, making it among the session's most active Swiss microcaps.

What is Meyka AI's recommendation for IGPH.SW stock?

Meyka AI rates IGPH.SW **62.67/100** with Grade **B** and Suggestion **HOLD**. The grade balances sector comparison, weak fundamentals, and volatile trading. This is informational, not financial advice.

What key risks should investors watch in IGPH.SW stock?

Key risks for IGPH.SW stock include thin liquidity, negative EPS **-0.03**, negative book value, product adoption and regulatory hurdles, and concentration in a small product set. Expect high short-term volatility.

Are there price targets for IGPH.SW stock?

We model scenario targets for context: conservative **CHF0.005** and bull-case **CHF0.020**, versus the current **CHF0.0015**. These are illustrative, not guarantees, and depend on liquidity and news flow.

CH Stocks

CHF0.0015 pre-market: IGEA Pharma (IGPH.SW) on SIX 05 Mar 2026, heavy volume

ByDanny Kontos March 5, 2026

IGPH.SW stock is trading at CHF0.0015 in the pre-market on 05 Mar 2026 after a -25.00% drop on heavy activity. IGEA Pharma N.V. (IGPH.SW) on SIX shows 2,033,000 shares traded versus an average volume of 193,941, marking it among the most active Swiss small-caps this session. The move follows low liquidity, a tiny market cap near CHF505,545, and stretched technicals with the 50-day average at CHF0.002 and the 200-day at CHF0.005. We examine drivers, valuation, and an outlook for investors.